According to Xilio Therapeutics's latest financial reports the company's current earnings (TTM) are -S$89.48 M. In 2022 the company made an earning of -S$0.12 B a decrease over its 2021 earnings that were of -S$97.75 M.The earnings displayed on this page is the company's Pretax Income.